Select Bibliography

Filter by any of these (after searching):

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 2 items

CALGB 100801 (Alliance): A phase II multi-center study of the addition of azacitidine (AZA) following allogeneic transplantation using a targeted busulfan based conditioning regimen for high risk myelodysplasia (MDS) and older patients with acute myeloid leukemia (AML)

Vij, Ravi , Hars, Vera , Blum, William , Shore, Tsiporah ... - EBMT - Bone Marrow Transplantation - 2015

Abstract - Primary - Primary - Transplant - CALGB-100801

Depth of Response to Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone Improves Over Time in Patients With Transplant-Eligible Newly Diagnosed Multiple Myeloma: GRIFFIN Study Update

Voorhees, Peter M , Kaufman, Jonathan L , Laubach, Jacob ... - EBMT - Bone Marrow Transplantation - 2020

Abstract - Secondary - Primary - Myeloma - AFT-29 (GRIFFIN)